Genovis AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0002485979
SEK
19.80
0.02 (0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Getinge AB
BONESUPPORT HOLDING AB
Xvivo Perfusion AB
MedCap AB
Surgical Science Sweden AB
CellaVision AB
Biotage AB
Vitrolife AB
Bactiguard Holding AB
Genovis AB
Elekta AB

Why is Genovis AB ?

1
The company has declared negative results for the last 2 consecutive quarters
  • INTEREST(HY) At SEK 0.57 MM has Grown at 100%
  • ROCE(HY) Lowest at 7.5%
  • RAW MATERIAL COST(Y) Grown by 7.05% (YoY)
2
With ROE of 8.76%, it has a expensive valuation with a 4.76 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -25.56%, its profits have risen by 2.8% ; the PEG ratio of the company is 28.5
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -25.56% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.14%
EBIT Growth (5y)
40.90%
EBIT to Interest (avg)
29.26
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.74
Sales to Capital Employed (avg)
0.56
Tax Ratio
9.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
47.78%
ROE (avg)
18.20%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
54
Industry P/E
Price to Book Value
4.76
EV to EBIT
48.81
EV to EBITDA
31.12
EV to Capital Employed
10.13
EV to Sales
8.90
PEG Ratio
28.53
Dividend Yield
NA
ROCE (Latest)
20.76%
ROE (Latest)
8.76%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 51.2 MM

-22What is not working for the Company
INTEREST(HY)

At SEK 0.57 MM has Grown at 100%

ROCE(HY)

Lowest at 7.5%

RAW MATERIAL COST(Y)

Grown by 7.05% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -24.59 %

PRE-TAX PROFIT(Q)

Lowest at SEK 2.55 MM

NET PROFIT(Q)

Lowest at SEK 1.31 MM

EPS(Q)

Lowest at SEK 0.02

Here's what is working for Genovis AB

Operating Cash Flow
Highest at SEK 51.2 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Depreciation
Highest at SEK 4.02 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for Genovis AB

Pre-Tax Profit
At SEK 2.55 MM has Fallen at -47.59%
over average net sales of the previous four periods of SEK 4.87 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (SEK MM)

Net Profit
At SEK 1.31 MM has Fallen at -78.39%
over average net sales of the previous four periods of SEK 6.08 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (SEK MM)

Interest
At SEK 0.57 MM has Grown at 100%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Pre-Tax Profit
Lowest at SEK 2.55 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (SEK MM)

Net Profit
Lowest at SEK 1.31 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (SEK MM)

EPS
Lowest at SEK 0.02
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (SEK)

Debt-Equity Ratio
Highest at -24.59 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 7.05% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales